retatrutide news recency 3 🚨Breaking: Retatrutide's first Phase T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide Half-Life & Pharmacokinetics: 6-Day

The hormone slows gastric emptying, prolonging the time food remains in your stomach and contributing to feelings of fullness, though this effect may diminish with chronic exposure

Even so, the article describes baseline thyroid function testing, including TSH and free T4, plus ongoing monitoring, as standard practice for adolescents on this therapy

See below to learn what you can do to manage those issues

Walking tends to make it better

Obesity is associated with a range of metabolic disruptions chronic inflammation, elevated insulin and glucose levels, dysregulated adipokine signaling, and an immunosuppressive environment all of which have been implicated in creating conditions that support tumor growth and survival

Some patients report reduced hunger and earlier satiety within the first week of GLP-1 treatment, though individual response varies considerably